Cabaletta Bio logo

Cabaletta Bio Share Price (NASDAQ: CABA)

$1.45

-0.05

(-3.33%)

Last updated on

Check the interactive Cabaletta Bio Stock chart to analyse performance

Cabaletta Bio stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.40
    Today's High:$1.51

    Day's Volatility :7.28%

  • 52 Weeks Low:$0.99
    52 Weeks High:$5.97

    52 Weeks Volatility :83.49%

Cabaletta Bio Stock Returns

PeriodCabaletta Bio IncSector (Health Care)Index (Russel 2000)
3 Months
-29.61%
3.6%
0.0%
6 Months
-13.17%
-7.7%
0.0%
1 Year
-71.34%
-12.6%
0.0%
3 Years
43.56%
10.2%
-4.1%

Cabaletta Bio Inc Key Stats

Check Cabaletta Bio key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.5
Open
$1.51
Today's High
$1.51
Today's Low
$1.4
Market Capitalization
$137.2M
Today's Volume
$1.2M
52 Week High
$5.97
52 Week Low
$0.9857
Revenue TTM
$0.0
EBITDA
$-148.0M
Earnings Per Share (EPS)
$-2.71
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-76.34%

Stock Returns calculator for Cabaletta Bio Stock including INR - Dollar returns

The Cabaletta Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cabaletta Bio investment value today

Current value as on today

₹33,940

Returns

₹66,060

(-66.06%)

Returns from Cabaletta Bio Stock

₹71,344 (-71.34%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Cabaletta Bio Stock

21%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Cabaletta Bio Stock from India on INDmoney has increased by 21% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cabaletta Bio Inc

  • Name

    Holdings %

  • Bain Capital Life Sciences Investors, LLC

    10.58%

  • T. Rowe Price Investment Management,Inc.

    7.43%

  • Jennison Associates LLC

    6.58%

  • Cormorant Asset Management, LLC

    5.47%

  • Alyeska Investment Group, L.P.

    5.25%

  • Adage Capital Partners Gp LLC

    3.97%

Analyst Recommendation on Cabaletta Bio Stock

Rating
Trend

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Cabaletta Bio(by analysts ranked 0 to 5 stars)

Cabaletta Bio Share Price Target

What analysts predicted

Upside of 696.94%

Target:

$11.56

Current:

$1.45

Cabaletta Bio share price target is $11.56, a slight Upside of 696.94% compared to current price of $1.45 as per analysts' prediction.

Cabaletta Bio Stock Insights

  • Price Movement

    In the last 7 days, CABA stock has moved down by -10.5%
  • CABA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 144.1%
  • CABA vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 64.2%

Cabaletta Bio Technicals Summary

Sell

Neutral

Buy

Cabaletta Bio is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cabaletta Bio Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cabaletta Bio Inc logo
0.69%
-13.17%
-71.34%
43.56%
-85.2%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Cabaletta Bio Inc

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. Its lead product candidate is resecabtagene autoleucel, a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T, which is in Phase 1/2 clinical trials for the treatment of dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, juvenile myositis, lupus nephritis, non-renal systemic lupus erythematosus, relapsing and progressive multiple sclerosis, mucocutaneous and mucosal pemphigus vulgaris (PV), systemic sclerosis, and generalized myasthenia gravis. The company also develops DSG3-CAART, a CAAR T cell therapy that is in Phase 1 clinical trial for the treatment of mucosal PV; and MuSK-CAART, an investigational cell therapy in Phase 1 trial for treating patients with anti-muscle-specific kinase (MuSK) antibody positive myasthenia gravis. It has collaborations with the University of Pennsylvania and the Children's Hospital of Philadelphia; Nanjing IASO Biotherapeutics Co., Ltd; Oxford Biomedica; Autolus Holdings (UK) Limited; and WuXi Advanced Therapies, Inc. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Organization
Cabaletta Bio
Employees
167
CEO
Dr. Steven A. Nichtberger M.D.
Industry
Health Technology

Key Management of Cabaletta Bio Inc

NameTitle
Dr. Steven A. Nichtberger M.D.
Co-Founder, Chairman, CEO & President
Dr. David J. Chang FACR, M.D., M.P.H.
Chief Medical Officer
Dr. Gwendolyn K. Binder Ph.D.
President of Science & Technology
Dr. Michael C. Milone M.D., Ph.D.
Co-Founder & Co-Chair of Scientific Advisory Board
Dr. Aimee Payne M.D., Ph.D.
Co-Founder & Co-Chair of Scientific Advisory Board
Mr. Anup Marda M.B.A.
Chief Financial Officer
Dr. Qing Sarah Yuan Ph.D.
Chief Technology Officer
Dr. Samik Basu M.D.
Chief Scientific Officer
Mr. Michael Gerard J.D.
General Counsel & Secretary
Ms. Heather Harte-Hall M.Sc.
Chief Compliance Officer

Important FAQs about investing in CABA Stock from India :

What is Cabaletta Bio share price today?

Cabaletta Bio share price today is $1.45 as on at the close of the market. Cabaletta Bio share today touched a day high of $1.51 and a low of $1.40.

What is the 52 week high and 52 week low for Cabaletta Bio share?

Cabaletta Bio share touched a 52 week high of $5.97 and a 52 week low of $0.99. Cabaletta Bio stock price today i.e. is closed at $1.45, lower by 75.71% versus the 52 week high.

How to invest in Cabaletta Bio Stock (CABA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cabaletta Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cabaletta Bio Shares that will get you 1.0345 shares as per Cabaletta Bio share price of $1.45 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cabaletta Bio Stock (CABA) from India?

Indian investors can start investing in Cabaletta Bio (CABA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cabaletta Bio stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Cabaletta Bio share’s latest price of $1.45 as on August 30, 2025 at 1:29 am IST, you will get 6.8966 shares of Cabaletta Bio. Learn more about fractional shares .

What are the returns that Cabaletta Bio has given to Indian investors in the last 5 years?

Cabaletta Bio stock has given -85.2% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?